Skip to main content
HERAMED LIMITED logo

HERAMED LIMITED — Investor Relations & Filings

Ticker · HMD ISIN · AU0000028367 LEI · 875500WOB41XBFTTJ477 ASX Manufacturing
Open in API
Filings indexed 524 across all filing types
Latest filing 2020-07-15 Regulatory Filings
Country AU Australia
Listing ASX HMD

About HERAMED LIMITED

https://hera-med.com/

HeraMED Limited is a medical technology company specializing in the development and commercialization of digital health solutions for maternity care. The company focuses on providing remote monitoring tools that bridge the gap between expectant mothers and healthcare providers. Its flagship product, HeraBEAT, is a medical-grade, smartphone-based fetal heart rate monitor designed for home use, allowing for accurate and reliable monitoring of fetal well-being. This hardware is integrated into the HeraCARE platform, a comprehensive digital maternity care solution that enables remote data management, personalized care plans, and seamless communication between patients and clinicians. By leveraging cloud-based technology and advanced sensors, the company aims to enhance prenatal care, improve clinical outcomes, and offer peace of mind through continuous, data-driven insights throughout the pregnancy journey.

Recent filings

Filing Released Lang Actions
Trading Halt 2 pages 502.1KB
Regulatory Filings Classification · 95% confidence The document is a market announcement from HeraMED Limited regarding a trading halt requested pending the release of a material collaboration agreement announcement. It is a short notice informing the market about the trading halt and does not contain any financial data, report, or detailed information about the agreement itself. It is not a financial report, earnings release, or any detailed filing but rather a regulatory announcement related to trading status. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-07-15 English
Results of Annual General Meeting 3 pages 124.5KB
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is an ASX announcement dated 14 July 2020 reporting the results of an Annual General Meeting (AGM) for HeraMED Limited. It includes detailed proxy voting results for resolutions passed at the AGM. The content focuses on the voting outcomes rather than the full AGM materials or presentations. The document length is 4912 characters, which is sufficient to include substantive voting results rather than just a brief announcement. The presence of detailed voting results aligns with the category for Declaration of Voting Results & Voting Rights Announcements (DVA). It is not an Annual Report (10-K), nor a Management Report (MDA), nor a Proxy Solicitation (PSI), but specifically the official results from shareholder votes at the AGM. Therefore, the correct classification is DVA with high confidence.
2020-07-13 English
Final Approvals Received to Commence Clinical Study 2 pages 117.5KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 13 July 2020 regarding final approvals received to commence a clinical study at Joondalup Health Campus. It describes the study's purpose, leadership, and strategic importance for the company HeraMED Limited. The content is focused on announcing the start of a clinical study and does not contain financial data, earnings, management discussion, or regulatory filings. It is not a report, transcript, or financial statement but rather a corporate announcement about operational progress and clinical trial commencement. Therefore, it fits best under the category of Regulatory Filings (RNS), which is the fallback for miscellaneous announcements that do not fit other specific categories.
2020-07-12 English
Results of Share Purchase Plan Offer 1 page 96.4KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 13 July 2020 regarding the results of a Share Purchase Plan (SPP) offer by HeraMED Limited. It details the amount raised, the number of shares issued, and plans for shortfall placement. The content focuses on capital raising activities and share issuance. The document length is 3150 characters, which is relatively short and is a direct announcement of financing activity rather than a full financial report or detailed analysis. There is no indication of it being a full annual or interim report, audit report, or earnings release. It is not a regulatory filing or report publication announcement since it contains substantive information about the capital raising event itself. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2020-07-12 English
Update on HMD SPP Offer 1 page 60.5KB
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the extension of the closing date for a Share Purchase Plan (SPP) offer. It provides details about the offer, the updated timetable, and instructions for shareholders. The document does not contain financial statements or detailed financial analysis but is an update on a capital raising activity. It is not a full report but an announcement related to financing activities. Therefore, it fits best under the category of Capital/Financing Update (CAP). The document length is short and focused on the SPP offer extension, confirming it is an update rather than a full report or regulatory filing.
2020-06-24 English
Becoming a substantial holder 2 pages 617.9KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 filed under the Corporations Act 2001, titled 'Notice of initial substantial holder.' It details the acquisition of a substantial shareholding in Heramed Limited by Freeman Road Pty Ltd, including voting power percentages and consideration paid. This matches the definition of a Major Shareholding Notification, which reports changes in significant share ownership levels crossing thresholds. The document length is short and focused solely on shareholding details, with no financial statements or other report content. Therefore, the correct classification is Major Shareholding Notification (MRQ).
2020-06-23 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.